Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name LOC389641
   Synonyms RP11-1149O23.3, LOC389641
   Region NA    Sequence
   Ensembl NA
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name pancreatic ductal adenocarcinoma
   ICD-0-3 C25.3  M8500/3
   Methods qPCR, RNAi, Western blot etc.
   Sample PDAC tissues, cell lines (SW1990, AsPC-1, PANC-1, MIAPaCa-2, BxPC-3 and Capan-2)
   Expression Pattern up-regulated
   Function Description

Here, we found that a novel lncRNA, LOC389641, was upregulated in PDAC tissues and cell lines. Knockdown of LOC389641 impaired cell proliferation and invasion and induced cell apoptosis in vitro, whereas overexpression of LOC389641 had the opposite effetc. Further, a significant negative correlation was observed between E-cadherin levels and LOC389641 levels in vivo. Knockdown of LOC389641 upregulated E-cadherin expression, but knockdown of E-cadherin had a limited influence on LOC389641. Importantly, after E-cadherin was inhibited, the enhancement of LOC389641 on cell invasion was hindered. Moreover, the expression of LOC389641 was closely associated with its genomic neighboring gene TNFRSF10A.

   Pubmed ID 26708505
   Year 2016
   Title Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner.
   External Links
   Links for  LOC389641 GenBank       HGNC       lncrnadb       Noncode
   Links for  pancreatic ductal adenocarcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.